Cocrystal Pharma (COCP) Deferred Taxes (2011 - 2018)

Cocrystal Pharma (COCP) has 5 years of Deferred Taxes data on file, last reported at $12.1 million in Q4 2018.

• For the quarter ending Q4 2018, Deferred Taxes rose 75.85% year-over-year to $12.1 million; the trailing twelve-month figure through Dec 2018 stood at $13.6 million (down 62.58% YoY), and the FY2018 full-year result was $13.6 million, up 97.41% from the prior year.
• Deferred Taxes advanced to $12.1 million in Q4 2018, from $486000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $29.4 million in Q4 2016 to a low of -$16000.0 in Q1 2017.
• A 4-year average of $7.2 million and a median of $554000.0 in 2018 frame the typical range for Deferred Taxes.
• Across the five-year window, Deferred Taxes tumbled 700.0% in 2017 and soared 2718.75% in 2018, its largest moves.
• Tracing COCP's Deferred Taxes over 4 years: stood at $15.2 million in 2015, then jumped by 93.36% to $29.4 million in 2016, then plunged by 76.57% to $6.9 million in 2017, then surged by 75.85% to $12.1 million in 2018.
• Business Quant data shows COCP's Deferred Taxes at $12.1 million in Q4 2018, $486000.0 in Q3 2018, and $554000.0 in Q2 2018.